Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Receivables (2020 - 2026)

Journey Medical filings provide 6 years of Change in Receivables readings, the most recent being $11.8 million for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 1674.16% to $11.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.3 million, a 532.2% increase, with the full-year FY2025 number at $19.3 million, up 532.2% from a year prior.
  • Change in Receivables hit $11.8 million in Q4 2025 for Journey Medical, up from $2.4 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $11.8 million in Q4 2025 to a low of -$10.4 million in Q2 2023.
  • Median Change in Receivables over the past 5 years was -$67000.0 (2022), compared with a mean of $346350.0.
  • The widest YoY moves for Change in Receivables: up 14170.59% in 2023, down 10538.55% in 2023.
  • Journey Medical's Change in Receivables stood at -$8.5 million in 2021, then soared by 99.4% to -$51000.0 in 2022, then skyrocketed by 14170.59% to $7.2 million in 2023, then plummeted by 110.41% to -$747000.0 in 2024, then skyrocketed by 1674.16% to $11.8 million in 2025.
  • The last three reported values for Change in Receivables were $11.8 million (Q4 2025), $2.4 million (Q3 2025), and -$2.8 million (Q2 2025) per Business Quant data.